# Flow Diverters Market

> Flow Diverters Market Research Report By Flow Diverter Type (Pipeline Embolization Device (PED), Flow Modulation Device (FMD), Stent-Assisted Coiling (SAC), Other Flow Diverter Types), By Application (Intracranial Aneurysms, Arteriovenous Malformations, Carotid Artery Disease, Other Applications), By Material (Nitinol, Cobalt-Chromium Alloy, Stainless Steel, Other Materials), By Delivery System (Over-the-Wire Delivery System, Catheter-Based Delivery System, Other Delivery Systems) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.94%
- **2024:** $ 1.24 Billion
- **2025:** $ 1.36 Billion
- **2035:** $ 3.51 Billion
- **Key Players:** Medtronic(US), Stryker (US), Boston Scientific (US), Terumo Corporation (JP), Abbott Laboratories (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), MicroVention (US), Penumbra (US)

**Report ID:** MRFR/HC/25940-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/flow-diverters-market-27617

---

## Market Summary

## **Flow Diverters Market Overview**

**As per MRFR analysis, the Flow Diverters Market Size was estimated at 1.24 (USD Billion) in 2024. The Flow Diverters Market Industry is expected to grow from 1.36 (USD Billion) in 2025 to 3.19 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 9.94% during the forecast period (2025 - 2034).**

## **Key Flow Diverters Market Trends Highlighted**

The Flow Diverters Market continues to witness significant growth, driven by the rising prevalence of aneurysms and other cerebrovascular disorders. The increasing adoption of minimally invasive surgical techniques and the growing awareness of flow diverters as a safe and effective treatment option are further bolstering market expansion.

Key market drivers include the aging population, which is more susceptible to cerebrovascular diseases, and the increasing availability of advanced neuroimaging techniques, which aid in the early detection and diagnosis of aneurysms.

Opportunities for growth lie in the development of next-generation flow diverters with improved efficacy, reduced invasiveness, and enhanced patient outcomes.

Recent market trends include the emergence of low-profile flow diverters, which offer improved navigability and reduced risk of complications, and the development of flow diverters specifically designed for complex and challenging anatomies.

Continued advancements in materials science and device design are expected to further shape the market landscape, leading to more effective and personalized treatment options for patients with [**cerebrovascular disorders**](../../../reports/cerebral-vascular-stent-market-9147).

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Flow Diverters Market Drivers**

### **Increasing Prevalence of Complex Aneurysms**

The primary factor that is augmenting the Flow Diverters Market is the rising prevalence of complex aneurysms among the geriatric population. Many of these aneurysms cannot be treated through traditional ways, such as coiling or stenting, because of their location or shape.

A flow diverter is a good treatment option for such complex aneurysms and is less invasive as well. Since it works by diverting blood flow from the aneurysm and promoting healing, the growing number of patients with complex aneurysms will continue to drive the demand for it in the coming years.

### **Technological Advancements in Flow Diverter Devices**

Technological progress in flow diverter devices serves as another significant driver of the Flow Diverters Market. Over the last few years, various improvements have been made in flow diverters, and new materials have been introduced.

For instance, the subsequent generation of flow diverters relies on more completely biocompatible materials, thereby reducing risks associated with the use of the tool, for example, thrombosis or inflammation.

Also, specific designs were developed that performed better in flow diversion and aneurysm sac occlusion rates. Such advances will continue to help the adoption of flow diverters in treating **complex aneurysms**.

### **Growing Awareness of Flow Diverters**

The increasing awareness about flow diverters in both the healthcare industry and patient pool is also aiding growth for the Flow Diverters Market. While flow diverters are a relatively new treatment modality for complex aneurysms, awareness about their benefits has been increasing among healthcare professionals due to which the numbers of recommendations is growing.

Moreover, patients are learning about flow diverters from information available online and through various patient advocacy groups. This growing awareness is expected to continue driving growth in demand for flow diverters.

## **Flow Diverters Market Segment Insights**

### **Flow Diverters Market Flow Diverter Type Insights**

The Flow Diverters Market is thriving, with the Flow Diverter Type segment specifically poised for growth.

Within this framework, the Pipeline Embolization Device (PED) stood out prominently, holding a significant market valuation of 0.4 USD Billion in 2023 and projected to escalate to 1.0 USD Billion by 2032. This growth is driven by its effectiveness in treating cerebral aneurysms, solidifying its majority holding in the Flow Diverters Market with significant demand.

Conversely, the Flow Modulation Device (FMD), valued at 0.3 USD Billion in 2023 and expected to rise to 0.8 USD Billion by 2032, is also gaining traction due to its innovative approach to flow diversion and enhanced treatment capabilities.

The prominence of FMD stemmed from its ability to modulate blood flow while allowing natural healing processes, thus complementing the overall market growth in a meaningful manner.

On another note, the Stent-Assisted Coiling (SAC) sub-segment, with valuations of 0.2 USD Billion for 2023 and anticipated to grow to 0.5 USD Billion by 2032, reflected the hybrid techniques being employed in **[neurovascular](../../../reports/neurovascular-devices-market-5544) interventions**, which combine stenting with traditional coiling methods.

Although representing a smaller segment of the Flow Diverter Type, its relevance is increasingly acknowledged among practitioners.

Lastly, the Other Flow Diverter Types accounted for a smaller valuation of 0.12 USD Billion in 2023, with no projected growth by 2032, showcasing its lesser influence in this competitive market landscape. This segmentation insight indicates a nuanced understanding of the Flow Diverters Market data, revealing avenues for targeted innovation while addressing unmet clinical needs.

Overall, the market's diverse offerings were fortified by advancements in technology, driving market growth and creating opportunities that align with evolving healthcare paradigms, thus fostering a robust Flow Diverters Market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Flow Diverters Market Application Insights**

The Flow Diverters Market encompasses various applications, including Intracranial Aneurysms, Arteriovenous Malformations, Carotid Artery Disease, and Other Applications. Intracranial Aneurysms represent a critical segment due to their prevalence and the need for effective treatment options.

Arteriovenous Malformations are also significant as they pose serious health risks, leading to a demand for innovative solutions in the market. Carotid Artery Disease is gaining attention as it is linked to severe cardiovascular events, highlighting the necessity for flow diverters in preventing complications.

The market growth is driven by technological advancements and an increasing awareness of minimally invasive procedures. However, challenges such as high treatment costs and regulatory hurdles may impact the overall market dynamics.

Opportunities abound in developing tailored therapies for diverse applications as emerging research continues to unlock new potentials within the Flow Diverters Market. This sector remains integral to addressing various vascular conditions, making it a focal point of research and development within the industry.

Overall, with the anticipated market growth, the significance of each application reinforces its role in enhancing patient outcomes through innovative treatment options.

### **Flow Diverters Market Material Insights**

The material segment plays a critical role in this expansion, comprising various key components that significantly impact market performance. Notably, Nitinol is recognized for its shape memory and superelastic properties, making it vital in designing effective flow diverters.

Cobalt-chromium alloy stands out due to its excellent biocompatibility and mechanical strength, catering to the rigorous demands of medical applications. Stainless Steel remains a major material due to its structural integrity and cost-effectiveness, dominating the market.

Other Materials also contribute to the market with innovative solutions that respond to specific therapeutic needs. The ongoing advancements in material science drive market growth, while factors such as increasing incidence of neurological disorders and technological developments in minimally invasive surgeries uplift the demand for effective flow diversion solutions.

However, challenges in material selection and stringent regulatory frameworks may impact the pace of growth. Overall, the materials involved in the Flow Diverters Market play a crucial role in enhancing product performance and efficacy, thereby influencing market dynamics.

### **Flow Diverters Market Delivery System Insights**

The Flow Diverters Market, particularly within the Delivery System segment, is a critical area experiencing significant growth. The Delivery System categories, including Over-the-Wire Delivery System and Catheter-Based Delivery System, play vital roles in the efficient deployment of flow diverters.

These systems offer unique advantages, such as enhanced accuracy and control during procedures, which are increasingly recognized in medical practice. The Over-the-Wire Delivery System, in particular, is noted for its precision, thereby dominating its respective niche in the market due to its effectiveness in complex cases.

Trends within the industry indicate an increasing demand for innovative technologies that improve patient outcomes and procedural efficiency, driving growth in this segment. However, challenges such as regulatory hurdles and high costs of advanced systems remain.

The Flow Diverters Market data suggests that there are significant opportunities for both established players and new entrants to innovate and capture market share amidst these dynamics, leading towards promising future statistics and robust **market growth**.

### **Flow Diverters Market Regional Insights**

Within the Regional segmentation, North America dominated with a market value of 0.4 USD Billion in 2023, significantly contributing to the overall market landscape, as it is a leading region for advanced medical technology and innovation.

Europe followed closely with a valuation of 0.3 USD Billion in 2023, supported by strong healthcare infrastructure and a rising prevalence of neurological disorders. South America, with a market value of 0.1 USD Billion, showcased emerging growth potential owing to increasing healthcare investments.

The Asia Pacific region, valued at 0.15 USD Billion in 2023, presented growth opportunities as hospitals adopt new technologies. Finally, the Middle East and Africa held a minor share with a valuation of 0.07 USD Billion, reflecting ongoing challenges in healthcare access and investment.

These regional dynamics highlight the varied pace of growth and opportunities, influenced by market trends, healthcare spending, and technological advancements across different geographies.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Flow Diverters Market Key Players And Competitive Insights**

Major players in the Flow Diverters Market are continuously investing in research and development to launch advanced products. Leading Flow Diverters Market players are focusing on expanding their product portfolio by introducing new products and enhancing existing ones to cater to the evolving needs of customers.

They are also adopting various strategies, such as mergers and acquisitions, to strengthen their market position. The Flow Diverters Market development is driven by the increasing prevalence of cerebrovascular diseases, technological advancements in flow diverter devices, and rising awareness about the benefits of flow diverters.

Stryker Corporation is a leading player in the Flow Diverters Market. The company offers a comprehensive range of flow diverter devices, including the Surpass Streamline Flow Diverter and the Surpass Evolve Flow Diverter.

Stryker Corporation is focused on providing innovative solutions for the treatment of complex neurovascular conditions. The company has a strong global presence and is committed to investing in research and development to drive Flow Diverters Market development.

MicroPort Scientific Corporation is another prominent player in the Flow Diverters Market. The company offers the Pipeline Embolization Device, which is a flow diverter stent used to treat intracranial aneurysms. MicroPort Scientific Corporation is focused on providing high-quality medical devices for the treatment of neurovascular conditions.

The company has a global presence and is committed to expanding its market reach through strategic partnerships and acquisitions.

### **Key Companies in the Flow Diverters Market Include**

- Terumo Corporation
- Boston Scientific Corporation
- Stryker Corporation
- Invatec
- Johnson Johnson Services, Inc.
- Microvention, Inc.
- Cook Medical
- Merit Medical Systems, Inc.
- Olympus Corporation
- Surmodics, Inc.
- Cardinal Health
- Medtronic
- Penumbra, Inc.
- Braun Melsungen AG

## **Flow Diverters Market Developments**

The rising prevalence of cerebrovascular diseases, increasing demand for minimally invasive procedures, growing awareness about flow diverters, and technological advancements in the field are fueling market growth. Key players in the market include Acandis GmbH, MicroVention Inc., and Stryker Corporation.

Recent developments in the market include the launch of new products, such as the SilkVista Flow Diverter by Acandis GmbH, and the expansion of geographical reach by key players. The increasing adoption of **flow diverters** in emerging markets is also expected to drive market growth in the coming years.

## **Flow Diverters Market Segmentation Insights**

### **Flow Diverters Market Flow Diverter Type Outlook**

- Pipeline Embolization Device (PED)
- Flow Modulation Device (FMD)
- Stent-Assisted Coiling (SAC)
- Other Flow Diverter Types

### **Flow Diverters Market Application Outlook**

- Intracranial Aneurysms
- Arteriovenous Malformations
- Carotid Artery Disease
- Other Applications

### **Flow Diverters Market Material Outlook**

- Nitinol
- Cobalt-Chromium Alloy
- Stainless Steel
- Other Materials

### **Flow Diverters Market Delivery System Outlook**

- Over-the-Wire Delivery System
- Catheter-Based Delivery System
- Other Delivery Systems

### **Flow Diverters Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### Rising Incidence of Neurovascular Disorders

The increasing prevalence of neurovascular disorders, such as aneurysms and arteriovenous malformations, is a primary driver for the Flow Diverters Market. As the population ages, the incidence of these conditions is expected to rise, leading to a greater demand for effective treatment options. According to recent estimates, the number of patients diagnosed with cerebral aneurysms is projected to reach millions annually, necessitating advanced medical interventions. Flow diverters, known for their minimally invasive nature, are becoming a preferred choice among healthcare providers. This trend indicates a growing market potential, as hospitals and clinics seek to adopt innovative solutions to address the rising patient needs. Consequently, the Flow Diverters Market is likely to experience substantial growth in response to these demographic shifts.

### Technological Innovations in Medical Devices

Technological advancements in medical devices are significantly influencing the Flow Diverters Market. Innovations such as improved materials, enhanced delivery systems, and advanced imaging techniques are making flow diverters more effective and easier to use. For instance, the introduction of bioresorbable materials has the potential to reduce complications associated with traditional devices. Furthermore, the integration of digital technologies, such as artificial intelligence and machine learning, is enhancing the precision of procedures involving flow diverters. As a result, healthcare providers are increasingly adopting these advanced devices, which is expected to drive market growth. The Flow Diverters Market is thus positioned to benefit from these technological trends, as they align with the demand for safer and more efficient treatment options.

### Rising Awareness and Education Among Patients

The increasing awareness and education among patients regarding neurovascular conditions is a significant driver for the Flow Diverters Market. As patients become more informed about their health, they are more likely to seek treatment options that are effective and less invasive. Educational campaigns and resources provided by healthcare organizations are contributing to this trend, leading to a higher rate of diagnosis and treatment. Market analysis indicates that patient engagement in healthcare decisions is on the rise, which is likely to influence the demand for flow diverters. As patients advocate for advanced treatment options, the Flow Diverters Market is expected to expand, driven by this heightened awareness and demand for innovative solutions.

### Growing Investment in Healthcare Infrastructure

The expansion of healthcare infrastructure is a crucial driver for the Flow Diverters Market. Governments and private entities are investing heavily in healthcare facilities, particularly in emerging economies. This investment is aimed at improving access to advanced medical technologies, including flow diverters. As new hospitals and specialized clinics are established, the demand for innovative treatment options is likely to increase. Reports indicate that healthcare spending is expected to rise significantly in the coming years, which will facilitate the adoption of advanced medical devices. Consequently, the Flow Diverters Market stands to gain from this trend, as healthcare providers seek to enhance their service offerings and improve patient outcomes.

### Increasing Focus on Minimally Invasive Procedures

The growing preference for minimally invasive procedures is reshaping the Flow Diverters Market. Patients and healthcare providers alike are recognizing the benefits of such techniques, which include reduced recovery times, lower risk of complications, and less postoperative pain. Flow diverters, which are designed to be deployed through small incisions, align perfectly with this trend. As more clinicians adopt these techniques, the demand for flow diverters is expected to rise. Market data suggests that the minimally invasive segment of the medical device industry is experiencing robust growth, further indicating a favorable environment for flow diverters. This shift towards less invasive options is likely to propel the Flow Diverters Market forward.

## Future Outlook

The Flow Diverters Market is projected to grow at a 9.94% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for minimally invasive procedures, and rising prevalence of vascular diseases.

**New opportunities:**

- Development of advanced bioresorbable flow diverters for enhanced patient outcomes. Expansion into emerging markets with tailored product offerings. Strategic partnerships with healthcare providers for integrated treatment solutions.

By 2035, the Flow Diverters Market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Type: Pipeline Embolization Device (PED) vs. Flow Modulation Device (FMD) (Fastest-Growing)

In the Flow Diverters Market, the segment value distribution shows a competitive landscape with Pipeline Embolization Devices (PED) holding the largest market share, primarily due to their growing acceptance for embolization procedures in various vascular conditions. Various healthcare institutions are emphasizing the adoption of PEDs, enhancing their utilization rates and overall penetration in the Flow Diverters Market. Flow Modulation Devices (FMD) have emerged as the fastest-growing segment, driven by advancements in technology and increasing efficacy in clinical applications, appealing to both practitioners and patients alike.

Flow Modulation Device (Dominant) vs. Stent-Assisted Coiling (Emerging)

The Pipeline Embolization Device (PED) is recognized for its exceptional performance in treating complex vascular lesions, establishing itself as the dominant player in this segment. Its popularity stems from demonstrated clinical efficacy and a favorable risk profile that clinicians appreciate. On the other hand, Flow Modulation Devices (FMD) represent an emerging solution, gaining traction due to their innovative design and ability to minimize complications often associated with traditional methods such as Stent-Assisted Coiling (SAC). Although SAC remains a tried and tested method, the contemporary advancements in flow modulation technology make FMD an appealing alternative, thereby changing the flow diverter dynamics.

### By Application: Intracranial Aneurysms (Largest) vs. Arteriovenous Malformations (Fastest-Growing)

In the Flow Diverters Market, the application segments are distinctly characterized by their market share distribution. [Intracranial Aneurysms](https://www.marketresearchfuture.com/reports/intracranial-aneurysm-market-41785) (IAAs) dominate the landscape, holding the largest share due to their prevalence and the increasing number of procedures being performed globally. Following closely, Arteriovenous Malformations (AVMs) are emerging as crucial contributors to the Flow Diverters Market, backed by increased awareness and advancements in minimally invasive techniques.

Intracranial Aneurysms (Dominant) vs. Arteriovenous Malformations (Emerging)

Intracranial Aneurysms represent the dominant application within the Flow Diverters Market. They are primarily treated using flow diverters, which have proven effective in managing this condition, characterized by localized bulging of blood vessels in the brain. The large market share is driven by a growing patient population and advancements in treatment technologies. In contrast, Arteriovenous Malformations are recognized as an emerging segment, experiencing rapid growth due to innovations in flow diverter design and increased focus on effective treatment strategies. Both segments are crucial as they reflect the evolving treatment paradigms and patient outcomes in cerebrovascular diseases.

### By Material: Nitinol (Largest) vs. Cobalt-Chromium Alloy (Fastest-Growing)

In the Flow Diverters Market, the material composition plays a critical role in determining performance, durability, and overall function. Nitinol has emerged as the largest segment, owing to its superior properties, including flexibility and shape memory. Cobalt-Chromium Alloy follows closely, recognized for its high strength and corrosion resistance, capturing a notable market share, while Stainless Steel and Other Materials cater to specific niche applications that require unique attributes.

Nitinol (Dominant) vs. Cobalt-Chromium Alloy (Emerging)

Nitinol remains the dominant material in the Flow Diverters Market due to its unique biocompatibility and ability to withstand extreme conditions, making it preferable for various medical applications. Its market position is bolstered by ongoing advancements in processing technologies and increased demand for minimally invasive procedures. Conversely, Cobalt-Chromium Alloy is an emerging player, characterized by its remarkable strength-to-weight ratio and resistance to wear. This alloy's ability to be used in high-stress environments is driving its adoption, making it one of the fastest-growing materials in the sector, particularly in applications requiring durability and reliability.

### By Delivery System: Over-the-Wire Delivery System (Largest) vs. Catheter-Based Delivery System (Fastest-Growing)

In the Flow Diverters Market, the Over-the-Wire Delivery System holds the largest share, benefiting from its established application in various end-user settings. This segment’s strength lies in its versatility and reliability, leading to widespread preference among healthcare professionals. Conversely, the Catheter-Based Delivery System is gaining traction, appealing particularly to those seeking minimally invasive solutions, thereby attracting a growing patient base.

Delivery Systems: Over-the-Wire (Dominant) vs. Catheter-Based (Emerging)

The Over-the-Wire Delivery System is currently the dominant player in the Flow Diverters Market, known for its robustness and adaptability in delivering flow diverters effectively. Its features cater to a wide range of procedural needs, offering clinicians confidence during complex interventions. On the other hand, the Catheter-Based Delivery System is emerging rapidly due to its innovative design aimed at enhancing patient comfort and procedural efficiency. This system enables intuitive navigation through blood vessels with minimal discomfort, positioning it as an increasingly popular choice in clinical scenarios demanding precision and care.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America is the largest market for flow diverters, accounting for approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of neurovascular diseases, and significant investments in medical technology. Regulatory support from agencies like the FDA further catalyzes innovation and product approvals, enhancing market dynamics. The United States leads the North American Flow Diverters Market, with key players such as Medtronic, Stryker, and Boston Scientific dominating the landscape. The competitive environment is characterized by continuous product development and strategic partnerships. Canada also contributes to the market, albeit at a smaller scale, focusing on improving healthcare access and technology adoption.

### Europe : Emerging Regulatory Frameworks

Europe is the second-largest market for flow diverters, holding around 30% of the global market share. The region's growth is propelled by an aging population, rising awareness of neurovascular conditions, and advancements in minimally invasive procedures. Regulatory frameworks, such as the EU Medical Device Regulation, are enhancing product safety and efficacy, thereby boosting market confidence and demand. Leading countries in Europe include Germany, France, and the UK, where significant investments in healthcare technology are evident. The competitive landscape features major players like B. Braun Melsungen AG and Terumo Corporation, who are actively involved in research and development. The presence of innovative startups also contributes to a dynamic market environment.

### Asia-Pacific : Rapidly Growing Market Potential

Asia-Pacific is witnessing rapid growth in the flow diverters market, accounting for approximately 20% of the global share. The region's expansion is driven by increasing healthcare expenditure, a growing patient population, and rising awareness of neurovascular diseases. Countries like China and India are investing heavily in healthcare infrastructure, which is expected to further boost market growth in the coming years. China is the largest market in the region, followed by Japan and India. The competitive landscape is evolving, with both multinational corporations and local players striving to capture market share. Key players such as Abbott Laboratories and MicroVention are focusing on expanding their presence through strategic collaborations and product innovations, enhancing their competitive edge.

### Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is gradually emerging in the flow diverters market, holding about 5% of the global share. The growth is primarily driven by increasing healthcare investments, rising awareness of neurovascular diseases, and improving healthcare infrastructure. Governments are focusing on enhancing medical services, which is expected to create new opportunities for market players in the coming years. Leading countries in this region include South Africa and the UAE, where healthcare reforms are paving the way for advanced medical technologies. The competitive landscape is still developing, with both local and international players exploring market entry strategies. Companies are increasingly focusing on partnerships and collaborations to enhance their market presence and service offerings.

## Competitive Benchmarking

The Flow Diverters Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for minimally invasive procedures. Key players such as Medtronic (US), Stryker (US), and Boston Scientific (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Medtronic (US) focuses on expanding its product portfolio through continuous research and development, while Stryker (US) emphasizes regional expansion and acquisitions to bolster its market share. Boston Scientific (US) appears to be concentrating on digital transformation initiatives, integrating advanced technologies into its product offerings, which collectively shapes a competitive environment that is increasingly reliant on innovation and strategic collaborations. In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency and reduce costs. The Flow Diverters Market is moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and solutions, fostering competition that drives innovation and quality improvements across the board. In August 2025, Medtronic (US) announced the launch of its latest flow diverter technology, which incorporates advanced biomaterials aimed at improving patient outcomes. This strategic move not only reinforces Medtronic's commitment to innovation but also positions the company to capture a larger share of the market by addressing specific clinical needs. The introduction of this technology is likely to enhance Medtronic's competitive edge, particularly in regions with high demand for advanced neurovascular solutions. In September 2025, Stryker (US) completed the acquisition of a leading neurovascular device manufacturer, which is expected to significantly enhance its product offerings in the Flow Diverters Market. This acquisition aligns with Stryker's strategy to expand its portfolio and strengthen its market presence. By integrating the acquired technologies, Stryker is poised to offer more comprehensive solutions, thereby increasing its competitiveness in a rapidly evolving market. In July 2025, Boston Scientific (US) entered into a strategic partnership with a technology firm to develop AI-driven solutions for flow diverters. This collaboration aims to leverage artificial intelligence to enhance procedural efficiency and patient outcomes. The integration of AI into their product development signifies a forward-thinking approach that could redefine operational standards in the industry, positioning Boston Scientific as a leader in innovative healthcare solutions. As of October 2025, the Flow Diverters Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence, which are reshaping competitive dynamics. Strategic alliances are becoming increasingly vital, as companies seek to combine resources and expertise to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and the ability to deliver superior patient outcomes. This shift underscores the importance of innovation and strategic partnerships in navigating the complexities of the current market landscape.

## Recent News & Developments

The rising prevalence of cerebrovascular diseases, increasing demand for minimally invasive procedures, growing awareness about flow diverters, and technological advancements in the field are fueling market growth. Key players in the market include Acandis GmbH, MicroVention Inc., and Stryker Corporation.

Recent developments in the Flow Diverters Market include the launch of new products, such as the SilkVista Flow Diverter by Acandis GmbH, and the expansion of geographical reach by key players. The increasing adoption of flow diverters in emerging markets is also expected to drive market growth in the coming years.

## Report Scope

| MARKET SIZE 2024 | 1.236 (USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 1.359 (USD Billion) |
| MARKET SIZE 2035 | 3.506 (USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.94% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medtronic (US), Stryker (US), Boston Scientific (US), Terumo Corporation (JP), Abbott Laboratories (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), MicroVention (US), Penumbra (US) |
| Segments Covered | Flow Diverter Type, Application, Material, Delivery System, Regional |
| Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the Flow Diverters Market. |
| Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation and competition in the flow diverters market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Flow Diverters Market as of 2024?**
A: The Flow Diverters Market was valued at 1.236 USD Billion in 2024.

**Q: What is the projected market size for the Flow Diverters Market in 2035?**
A: The market is projected to reach 3.506 USD Billion by 2035.

**Q: What is the expected CAGR for the Flow Diverters Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Flow Diverters Market during 2025 - 2035 is 9.94%.

**Q: Which companies are considered key players in the Flow Diverters Market?**
A: Key players in the market include Medtronic, Stryker, Boston Scientific, Terumo Corporation, Abbott Laboratories, Johnson & Johnson, B. Braun Melsungen AG, MicroVention, and Penumbra.

**Q: What are the main types of flow diverters and their market valuations?**
A: The main types include Pipeline Embolization Device (PED) valued at 1.396 USD Billion and Flow Modulation Device (FMD) valued at 1.036 USD Billion by 2035.

**Q: Which applications dominate the Flow Diverters Market?**
A: Intracranial Aneurysms and Arteriovenous Malformations are the dominant applications, projected to reach 1.386 USD Billion and 1.036 USD Billion respectively by 2035.

**Q: What materials are primarily used in flow diverters and their market performance?**
A: Nitinol is projected to reach 1.02 USD Billion, while Cobalt-Chromium Alloy is expected to reach 0.85 USD Billion by 2035.

**Q: What delivery systems are utilized in the Flow Diverters Market?**
A: The Catheter-Based Delivery System is projected to reach 1.392 USD Billion, while the Over-the-Wire Delivery System is expected to reach 1.036 USD Billion by 2035.

**Q: How does the market for other flow diverter types compare to the main types?**
A: Other Flow Diverter Types are projected to reach 0.386 USD Billion by 2035, indicating a smaller but notable segment.

**Q: What trends are influencing the growth of the Flow Diverters Market?**
A: The increasing prevalence of vascular diseases and advancements in medical technology are likely driving the growth of the Flow Diverters Market.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/flow-diverters-market-27617*